During the past decade, Arizona Digestive Health Mesa - East conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arizona Digestive Health Mesa - East" are "Crohn's Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Arizona Digestive Health Mesa - East" in a lesser frequency.

Most popular intervention types in "Arizona Digestive Health Mesa - East" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Digestive Health Mesa - East" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Arizona Digestive Health Mesa - East". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Arizona Digestive Health Mesa - East, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Digestive Health Mesa - East, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".